Kiwi biotech firm seeking clearance for Zika diagnostic

Kiwi biotech firm Ubiquitome is seeking clearance from the US Food and Drug Administration (FDA) to secure a Zika diagnostic test before the Rio de Janeiro Olympics in August.

The Auckland-based company has launched a crowdfunding campaign with the hopes that it will accelerate the manufacture of the FDA-authorised molecular test.

Ubiquitome founder and CEO Dr Paul Pickering says the company wants to minimise the impact of the Zika virus by making it readily available.

Read more